>>> US Gapping up

Gapping up
In reaction to earnings/guidance:
  • EOSE +36.9%, VELO +17.9%, SLS +17.4% (also provides clinical update), NXT +14.3% (also to acquire Zigor Corp's power conversion business and Apex Power), TSEM +13.6%, AIP +11.3% (also CFO to retire), ANDG +8.8%, GLBE +8.4%, PSFE +7.9%, RSKD +7.6%, ICL +5.6%, CMPS +5.6%, ELMD +4.8%, IPHA +4.4%, VEON +4.3%, MAZE +3.3%, KRNT +3.3%, TRMD +2.7%, TII +2.6%, KYTX +1.7%, KYIV +1.3%, UPB +1%
Other news:
  • PSNL +12.2% (receives expanded Medicare coverage for NeXT Personal immunotherapy monitoring test)
  • BRSL +10.5% (signed a multi-year contract extension with Lottotech)
  • CPA +8.7% (reports April traffic growth of 16.7%)
  • TBI +7% (TrueBlue confirms board reviewing unsolicited proposal from HireQuest)
  • HQI +5.4% (TrueBlue confirms board reviewing unsolicited proposal from HireQuest)
  • SOPH +5.4% (announced a partnership with Synnovis to bring liquid biopsy testing to lung and breast cancer patients across the U.K. as part of NHS England's 'revolutionary blood test-first' program)
  • VYGR +4.3% (Single IV dose of VY1706 well tolerated, reduced tau in 3-Month GLP Toxicology data; clinical trial in Alzheimer's Disease Expected H2 2026)
  • SEZL +3.4% (SEZL provides update on antitrust case against SHOP)
  • ORLA +3.2% (Equinox Gold (EQX) to acquire Orla Mining in at-market combination creating North American senior gold producer)
  • GYRE +2.7% (China drug regulator accepts NDA for F351 for chronic hepatitis B-induced liver fibrosis)
  • VFS +2.6% (to split certain assets of VinFast Trading and Production JSC into a new formed entity)
  • XWIN +2.6% (to change ticker to XMAX)
  • FLNC +2.5% (prices secondary offering of 20.0 mln shares of common stock at 21.00 per share)
  • SANA +2.1% (presents preclinical data)
  • INNV +1.9% (names new COO)
  • QTRX +1.7% (CFO to step down)
  • IONQ +1.6% (opens new quantum computing R&D lab)
  • AAPG +1.5% (to present 17 Clinical Advances at 2026 European Hematology Association Congress)
  • IIIV +1.4% (authorizes new $100 mln share repurchase program)
  • NVO +1.1% (highlights additional Wegovy pill data showing strong weight loss and mobility benefits)
  • EQX +1.1% (Equinox Gold (EQX) to acquire Orla Mining in at-market combination creating North American senior gold producer)
  • USAR +1% (Texas awards $14.2 mln grant)